Eyenovia, Inc. Profile Avatar - Palmy Investing

Eyenovia, Inc.

Eyenovia, Inc., a clinical stage ophthalmic company, engages in developing therapeutics based on its proprietary microdose array print platform technology. The company focuses on developing clinical microdosing of formulations of ophthalmic pharmaceutica…

Biotechnology
US, New York [HQ]

Document Reader

Click To Read:

DEF 14-A Proxies

Not a single DEF 14-A proxy doc.

10-K Filings

Not a single 10-K doc.

10-Q Filings

Not a single 10-Q doc.

LDA 1/2 Filings [Lobbying]

Not a single LDA doc.

End of EYEN's Analysis
CIK: 1682639 CUSIP: 30234E104 ISIN: US30234E1047 LEI: - UEI: -
Secondary Listings
EYEN has no secondary listings inside our databases.